Elegen, a leader in next-generation DNA synthesis and production, announced a Series B financing of $35 million led by Triatomic Capital. Also joining the round include strategic investors GSK – which ...
Ribbon's launches Synthetic MiroSynth Cell-Free DNA product manufactured without bacterial cloning steps. The company has also launched the MiroMine kit, allowing customers to create synthetic DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results